Blood type A and familial breast cancer
Abstract
The association between blood type A and breast cancer was evaluated in 648 patients with family histories of the disease, 1897 unselected patients, 4577 institutional blood donor controls, and 14,508 extramural blood donor controls. The familial patients were classified into three pedigree groups in which the lifetime breast cancer risks to first‐degree relatives ranged from 11% to 32%. In the pedigree group associated with a relatively low risk to relatives, the authors saw a significant excess of blood type A individuals when compared with either control group. The unselected patient population, which was considered to refer to a general series of patients, also showed an excess of blood type A individuals with either control but a significant excess only in comparison with institutional controls. Patients from high‐risk pedigrees with inherited forms of breast cancer showed no association when compared with either control group. The effect of blood type A on breast cancer risk was considered too small to be of use in identifying women at high risk. The results further suggested that the effect of blood type A on breast cancer development was capable of being masked by the effect of breast cancer susceptibility genes and/or that the inherited and noninherited types involve different etiologic mechanisms.
Number of times cited: 21
- S. Zouine, F. Marnissi, N. Otmani, M. Bennani Othmani, M. El Wafi, K. Kojok, Y. Zaid, N. Tahiri Jouti and N. Habti, ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women, Medical Oncology, 33, 7, (2016).
- Seyyed Mostafa Shiryazdi, Saeed Kargar, Mohammad Ali Dehghan, Hosein Neamatzadeh and Mohaddeseh Aboueian-Jahromi, Frequency Distribution of ABO/Rh Blood Group Systems in Breast Cancer, Yazd, 2007 - 2013, Zahedan Journal of Research in Medical Sciences, 17, 8, (2015).
- Su‐Yu Miao, Wenbin Zhou, Ling Chen, Shui Wang and Xiao‐An Liu, Influence of ABO blood group and Rhesus factor on breast cancer risk: A meta‐analysis of 9665 breast cancer patients and 244 768 controls, Asia-Pacific Journal of Clinical Oncology, 10, 2, (101-108), (2013).
- A.H. Mansour, Mohammed Amin Mohammed, Rokia Anwar, M.E. Elzafrany and Nesreen Moustafa Omar, ABO Blood Group and Risk of Malignancies in Egyptians, International Journal of Cancer Research, 10, 2, (81), (2014).
- Maninder Kaur, Association between ABO blood group and osteoporosis among postmenopausal women of North India, HOMO - Journal of Comparative Human Biology, 65, 6, (516), (2014).
- V. Zivaljevic, N. Slijepcevic, I. Paunovic, A. Diklic, N. Kalezic, J. Marinkovic, R. Zivic, B. Vekic and S. Sipetic, Risk Factors for Anaplastic Thyroid Cancer, International Journal of Endocrinology, 2014, (1), (2014).
- Salem Abobaker and Muhammad Kamil, Incidence of Breast Cancer in a Primary Hospital in Relation to ABO Blood Groups System, Journal of Medical and Bioengineering, 3, 1, (74), (2014).
- Bai-Lin Zhang, Na He, Yu-Bei Huang, Feng-Ju Song and Ke-Xin Chen, ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis, Asian Pacific Journal of Cancer Prevention, 15, 11, (4643), (2014).
- Margaret A. Gates, Mousheng Xu, Wendy Y. Chen, Peter Kraft, Susan E. Hankinson and Brian M. Wolpin, ABO blood group and breast cancer incidence and survival, International Journal of Cancer, 130, 9, (2129-2137), (2012).
- Arseniy E. Yuzhalin and Anton G. Kutikhin, ABO and Rh Blood Groups in Relation to Ovarian, Endometrial and Cervical Cancer Risk Among The Population of South-East Siberia, Asian Pacific Journal of Cancer Prevention, 13, 10, (5091), (2012).
- N. D. Rambaruth, P. Greenwell and M. V. Dwek, The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer, Glycobiology, 22, 6, (839), (2012).
- Qiwen Ben, Kaixuan Wang, Yaozong Yuan and Zhaoshen Li, Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: A case–control study, International Journal of Cancer, 128, 5, (1179-1186), (2010).
- Miao-Zhen Qiu, Dong-Sheng Zhang, Dan-Yun Ruan, Hui-Yan Luo, Zhi-Qiang Wang, Zhi-Wei Zhou, Feng-Hua Wang, Yu-Hong Li and Rui-Hua Xu, A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China, Medical Oncology, 28, S1, (268), (2011).
- Alvaro L. Ronco, Mario Stoll, Eduardo De Stéfani, Juan E. Maisonneuve, Beatriz A. Mendoza and Hugo Deneo-Pellegrini, Rh factor, family history and risk of breast cancer: A case–control study in Uruguay, Cancer Detection and Prevention, 10.1016/j.cdp.2008.12.005, 32, 4, (277-285), (2009).
- Barry S Mitchell, Susan A Brooks, Anthony J.C Leathem and Udo Schumacher, Do HPA and PHA-L have the same binding pattern in metastasizing human breast and colon cancers?, Cancer Letters, 123, 1, (113), (1998).
- David E. Anderson, Familial versus sporadic breast cancer, Cancer, 70, S4, (1740-1746), (2006).
- Pamela L. Horn and W. Douglas Thompson, Risk of contralateral breast cancer associations with histologic, clinical, and therapeutic factors, Cancer, 62, 2, (412-424), (2006).
- Laufey Tryggvadottir, Hrafn Tulinius and James McD. Robertson, Familial and sporadic breast cancer cases in Iceland: A comparison related to ABO blood groups and risk of bilateral breast cancer, International Journal of Cancer, 42, 4, (499-501), (2006).
- Howard R. Bierman, Michael R. Faith and Morgan E. Stewart, Digital Dermatoglyphics in Mammary Cancer, Cancer Investigation, 6, 1, (15), (1988).
- F.J. Grundbacher, A. Leathem and Susan Brooks, HELIX POMATIA LECTIN-BINDING AND PREDICTIVE VALUE IN BREAST-CANCER, The Lancet, 330, 8568, (1145), (1987).
- Christine L. Carter and Marc S. Micozzi, Genetic factors in human breast cancer, American Journal of Physical Anthropology, 29, S7, (161-180), (2005).
